A Hospital Based Cross Sectional Study to assess Knowledge Regarding Lymphatic Filariasis & Mass Drug Administration

Author(s):  
Gouri Ku Padhy ◽  
Rajib Kumar Ray ◽  
Sangeeta Das ◽  
Manas Ranjan Pani
2014 ◽  
Vol 40 (1) ◽  
pp. 34-40 ◽  
Author(s):  
Ram Kumar Adhikari ◽  
Jeevan Bahadur Sherchand ◽  
Shiva Raj Mishra ◽  
Kamal Ranabhat ◽  
Rajendra Raj Wagle

2021 ◽  
Vol 8 (11) ◽  
pp. 364-369
Author(s):  
Vikas Oraon ◽  
Vidushi Topno

Lymphatic filariasis is a mosquito born disease infecting over 120 million people globally. This is a community based cross-sectional study done to assess the prevalence of disease in Dumka District of Jharkhand. Three years data (2018-2020) were used to know the disease spectrum in this region. The disease mostly presented itself in its chronic forms. Prevalence of the disease has decreased in three years duration. Lymphedema cases were predominant as it was seen in both male and female. The study showed Lymphedema cases as 52% in 2018, 88% in 2019 and 98% in 2020. Overall disease is significantly higher in males than in female. But, Elephantiasis is more frequent in females. Present study reveals that there is remarkable impact of ELF program showing significant reduction in number of cases in three years duration. But the study indicates that the disease still continues to be the major cause of disability and poverty. Keywords: Lymphatic filariasis, Mass drug administration, Elimination of Lymphatic Filariasis.


Author(s):  
Ram Kumar Panika ◽  
Rupesh Sahu

Background: Lymphatic filariasis is the second leading cause of disability worldwide accounting for more than 5 million disability adjusted life years annually. It has been a major public health problem in India which leads to irreversible chronic manifestations which are responsible for considerable economic loss and severe physical disability to the affected individuals. Mass drug administration (MDA) means administration of diethylcarbamazine and albendazole tablets to all people (excluding children <2 years, pregnant women, seriously ill persons) in endemic areas once in a year. The objective of the study was to assess coverage, compliance of MDA and awareness about lymphatic filariasis in Tikamgarh district of Madhya Pradesh.Methods: Cross-sectional study was conducted and total 120 households were surveyed in four randomly selected clusters of Tikamgarh district of Madhya Pradesh.Results: Out of total 743 persons 678 (91.25%) persons were eligible for MDA. Coverage rate was 86.57% and compliance rate was 74.27%. The main reason for non-compliance was not having the concerned disease (55.78%) followed by fear of side effect (22.31%). Only 40.83% among the surveyed families were aware about MDA and only 45.83% respondents had heard about lymphatic filariasis.Conclusions: There is coverage and compliance gap and awareness about the lymphatic filariasis and MDA program is limited. Drug compliance need to be improved and awareness need to be raised. MDA program should not be confined to tablet distribution only and due importance should be given to compliance rate.


Author(s):  
Vivek Sharma ◽  
Vikrant Kabirpanthi

Background: Lymphatic filariasis is a major public health problem which is caused by Wuchereria Bancrofti and Brugia Malai. The disease is endemic in 250 districts in 20 states and UTs. In India national health policy 2002 envisages elimination of lymphatic filariasis by 2015. Important strategy for elimination of lymphatic filariasis is through annual mass drug administration of single dose of DEC for 5 year or more to the eligible population. Present cross sectional study was carried out to assess drug compliance after mass drug administration of DEC and the factors responsible for poor compliance among the population of Satna district of MP.Methods: The present study was a cross-sectional study which was carried out in filarial endemic Satna district. In this district 120 houses from 3 CHC & one urban ward was randomly selected. 30 households each from 3 rural and one urban site were interviewed related to MDA for DEC.Results: Coverage of tablet distribution in Satna was 90.9%. Consumption of drug among the people who received the drug was 87.97%, while the total effective consumption was 79.9%. Drug distributors ensured consumption of drug in only 16.9%.Conclusions: Focus of MDA is primarily to mere distribution of drug. There is need to give emphasis on consumption of drug, health education, common side effects and its management in order to increase effective coverage rate. 


2020 ◽  
Vol 20 (2) ◽  
pp. 167-174
Author(s):  
Ilo Dicko ◽  
Yaya Ibrahim Coulibaly ◽  
Modibo Sangaré ◽  
Bismark Sarfo ◽  
Priscillia Awo Nortey

Background: Lymphatic filariasis (LF) is a parasitic disease that has been targeted for elimination through the Mass Drug Administration (MDA.) Although the MDA started in the Ankobra community in Ghana in 2000, LF prevalence as reported in 2014 was relatively high (4.5%). Non-compliance to the MDA has been associated with the persistent LF prevalence in endemic regions. Objective: This study determined the factors associated with the non-compliance to the MDA among patients living in the Ankobra community, Ghana. Methods: A cross-sectional study using a one-stage cluster sampling method was used to collect data between June and July, 2017 in Ankobra. Questionnaires were used to collect data from health workers, the MDA drug distributors and study participants in Ankobra. Data analysis was performed using STATA 14. Logistic regression was used to measure the degree of association between the dependent (non-compliance) and independent variables. Non-compliance rate was defined as the percentage of individuals who self-reported that they did not actually swallow the drugs provided during the MDA. Results: The MDA coverage and non-compliance rates were 73.5% (147/200) and 33.33% (49/147) respectively. The main reason for non-compliance was fear of drug adverse events (75.51%, 37/49). Thought of “not being susceptible to LF” was significantly associated with the non-compliance (aOR= 2.83, [CI= 1.15, 6.98]). Conclusion: Health education about the susceptibility of residents getting LF disease in endemic community must be intensified to improve compliance to MDA medication ingestion and thus meet the Global Elimination of Lymphatic Filariasis by 2020.


2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Zerihun Zerdo ◽  
Tsegaye Yohanes ◽  
Befikadu Tariku

Mass drug administration (MDA) to the most risky population including school-age children (SAC) is the central strategy to control soil-transmitted helminth (STH) infection. The present study was aimed at estimating the prevalence of STHs reinfection three months posttreatment and associated risk factors among SAC in Chencha district. A cross-sectional study design was employed from April 20 to May 5, 2015, to enroll 408 SAC. Structured questionnaire and Kato-Katz thick smear technique were used to interview parents or guardians and quantify the number of eggs per gram of stool. Pearson chi-square and logistic regression were used to assess the association between predictor variable and STH reinfection. The prevalence of STHs within three months of mass chemotherapy among SAC was 36.8% which is 93.4% of the prevalence (39.4%) before treatment. The estimated prevalence of reinfection (95%CI) forAscaris lumbricoides,Trichuris trichiura, and hookworms was 23.8% (21.1–28.2), 16.2% (12.7–20.1), and 1.0% (0.3–2.5), respectively. Children of merchant fathers were more likely to be reinfected by STHs in Chencha district. In conclusion, there is rapid reinfection after mass chemotherapy among SAC in Chencha district. Further studies should be carried out to generate cost efficient methods that can supplement mass drug administration to accelerate the control of STHs.


Sign in / Sign up

Export Citation Format

Share Document